Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis

CM Artlett; S Sassi-Gaha; Jennifer Hope; CA Feghali-Bostwick; Peter Katsikis

doi:10.1186/s13075-017-1331-z

Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis

CM Artlett, S Sassi-Gaha, Jennifer Hope, CA Feghali-Bostwick, Peter Katsikis

Immunology

Research output: Contribution to journal › Article › Academic › peer-review

99 Citations (Scopus)

6 Downloads (Pure)

Original language	Undefined/Unknown
Article number	144
Journal	Arthritis Research & Therapy
Volume	19
DOIs	https://doi.org/10.1186/s13075-017-1331-z
Publication status	Published - 2017

Access to Document

10.1186/s13075-017-1331-z

REPUB_100733-OA.pdfFinal published version, 863 KB

http://hdl.handle.net/1765/100733

Cite this

@article{7c4313d9097f48f484c17cadf2866e3b,

title = "Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis",

author = "CM Artlett and S Sassi-Gaha and Jennifer Hope and CA Feghali-Bostwick and Peter Katsikis",

year = "2017",

doi = "10.1186/s13075-017-1331-z",

language = "Undefined/Unknown",

volume = "19",

journal = "Arthritis Research and Therapy",

issn = "1478-6354",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis

AU - Artlett, CM

AU - Sassi-Gaha, S

AU - Hope, Jennifer

AU - Feghali-Bostwick, CA

AU - Katsikis, Peter

PY - 2017

Y1 - 2017

U2 - 10.1186/s13075-017-1331-z

DO - 10.1186/s13075-017-1331-z

M3 - Article

SN - 1478-6354

VL - 19

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

M1 - 144

ER -